Syros Pharmaceuticals Stock (NASDAQ: SYRS) stock price, news, charts, stock research, profile.
Open | $6.01 |
Close | $6.27 |
Volume / Avg. | 65.49K / 107.61K |
Day Range | 5.89 - 6.32 |
52 Wk Range | 2.09 - 8.17 |
Market Cap | $167.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 5.32% |
Days to Cover | 12.51 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Syros Pharmaceuticals (NASDAQ:SYRS) through any online brokerage.
Other companies in Syros Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Atossa Therapeutics (NASDAQ:ATOS) and Tevogen Bio Holdings (NASDAQ:TVGN).
There is no analysis for Syros Pharmaceuticals.
Syros Pharmaceuticals has a consensus price target of $14.83.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $6.24 last updated July 18, 2024 at 5:20 PM EDT.
There are no upcoming dividends for Syros Pharmaceuticals.
Syros Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Syros Pharmaceuticals.
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.